Worldwide study to end lung cancer

15 September 2017 - 31 December 2020

Be part of a historic moment in the fight against lung cancer.


Participate in a worldwide study to end lung cancer.


Your body contains a series of biomarkers that allow doctors to identify your predisposition to develop lung cancer. These biomarkers are key to the development of effective early diagnostic methods and even to prevent lung cancer from progressing in some patients.
Take part in this study led by The University of Texas MD Anderson Cancer Center in Houston and help us find the best way to end lung cancer.

Who can take part in the study?

  • Men women who are smokers or ex-smokers.
  • Over 50 years of age.
  • Who have smoked around a packet of cigarettes a day for 30 years.

What does the study consist of?


The study will last 5 years and 10,000 people from around the world will take part. The collaboration of the participants will be quick and simple: once a year, over the 5 years of the study, they will have a free check-up consisting of:

  • A low-contrast, non-contrast chest CT scan to detect any nodules or disease early on

  • A blood test

  • A consultation with a physician specializing in pulmonology

  • A spirometry test

After each check-up you will be personally informed of your results. The collected samples, fully anonymized, will be processed and will allow researchers to discover biomarkers that help predict the onset of lung cancer in the future with a single drop of blood.


Call 900 878 444 or write to to make an appointment or for further information.



MD Anderson Cancer Center Madrid
Calle de Arturo Soria, 270 28033